Pharmaceuticals (26) | Change of Control Agreements (26)

Browse by Company

Recent Contracts

Executive Change of Control Policy, as amended December 9, 2020 (DURECT CORP, Filed With SEC on March 5, 2021)
Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Atabak Mokari, dated March 1, 2021 (Corcept Therapeutics Incorporated, Filed With SEC on March 1, 2021)
Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
GW UK Change in Control and Severance Benefit Plan (GW Pharma Limited / GW Research Limited) (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement, dated February 25, 20201, between Greenwich Biosciences,... (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Change in Control and Severance Benefit Plan Participation Agreement, dated February 25, 2021, by and between GW Pharmaceuticals plc and Geoffrey Guy (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Form of Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement for Existing EVP Participation (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Form of Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement for EVP Participation (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Form of GW UK Change in Control and Severance Benefit Plan Participation Agreement (GW PHARMACEUTICALS PLC, Filed With SEC on February 26, 2021)
Change in Control Severance Benefit Plan, effective January 1, 2017, as amended by First Amendment to Change in Control Severance Benefit Plan, effective October 2, 2019 (Aclaris Therapeutics, Inc., Filed With SEC on February 25, 2021)